A comparative study of the binding properties, dipeptidyl peptidase‐4 (DPP‐4) inhibitory activity and glucose‐lowering efficacy of the DPP‐4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice
Effect of single‐dose DPP‐4 inhibitor sitagliptin on β‐cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug‐naïve, well‐controlled type 2 diabetes subjects
Tags: antidiabetic drug, antihyperglycemic drug, diabetes, dipeptidyl peptidase-4 (DPP-4) inhibitor, Januvia®, MK-0431
BASi Method Number SAP.1403
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
